Erectile dysfunction(ED) After 40: Why It Happens and What Helps

What Most Men Don’t Know About Erectile Dysfunction

Erectile dysfunction (ED) is far more common than most people realize—and it’s not just a normal part of aging. Millions of men experience difficulty achieving or maintaining an erection, yet many suffer in silence due to embarrassment or the belief that nothing can be done beyond medication.

Pathophysiology of Erectile Dysfunction (ED)

Erectile dysfunction (ED) occurs when the normal processes required for an erection are disrupted. A healthy erection depends on intact nerve signaling, adequate blood flow, healthy blood vessels, responsive smooth muscle, and proper hormone balance.

The most common underlying problem in ED is impaired blood flow.

Key Mechanisms Involved in ED

1. Endothelial Dysfunction (Most Common Cause)

Damage to the lining of blood vessels reduces nitric oxide production, which is essential for penile blood vessel dilation. This leads to insufficient blood flow for erections.

Common contributors include hypertension, diabetes, smoking, high cholesterol, and aging.

2. Vascular Insufficiency

Narrowed or stiffened penile arteries limit blood inflow. Because penile arteries are very small, they are often affected earlier than heart arteries, making ED an early sign of cardiovascular disease.

Pathology includes:

• Arterial narrowing

• Reduced arterial compliance

• Impaired blood inflow

• Failure to maintain intracavernosal pressure

This results in:

• Weak erections

• Difficulty sustaining erections

• Loss of rigidity

  
  

3. Impaired Nitric Oxide–cGMP Signaling

Reduced nitric oxide release disrupts the chemical pathway that allows smooth muscle relaxation and blood trapping in the penis. ED medications enhance this pathway but do not repair underlying vessel damage.

Causes include:

• Oxidative stress

• Chronic inflammation

• Diabetes-related endothelial damage

PDE-5 inhibitors (e.g., sildenafil) act downstream by preserving cGMP—but they do not restore nitric oxide production itself.

4. Smooth Muscle Dysfunction & Tissue Changes

Chronic poor circulation leads to smooth muscle loss, fibrosis, and venous leakage, preventing the penis from maintaining rigidity.

Chronic hypoxia or inflammation leads to:

• Smooth muscle apoptosis

• Increased collagen deposition

• Corporal fibrosis

• Reduced tissue elasticity

This causes veno-occlusive dysfunction, where blood enters the penis but leaks out too quickly.

5. Neurogenic Factors

Nerve damage from diabetes, spinal cord injury, pelvic surgery, or neurologic conditions interferes with erection initiation.

Neurogenic ED may result from:

• Diabetes-related neuropathy

• Spinal cord injury

• Pelvic surgery (e.g., prostatectomy)

• Multiple sclerosis or stroke

Damage disrupts nitric oxide release and neural stimulation.

6. Hormonal Factors

Low testosterone can worsen ED by reducing libido and nitric oxide activity, but it is rarely the sole cause.

Testosterone plays a permissive role in erectile physiology by:

• Maintaining nitric oxide synthase activity

• Supporting libido

• Preserving penile tissue integrity

Low testosterone can worsen ED but is rarely the sole cause.

7. Psychological Factors

Stress, anxiety, depression, and performance anxiety increase sympathetic nervous system activity, which suppresses erectile response.

Mechanisms include:

• Increased sympathetic tone

• Elevated cortisol

• Reduced parasympathetic activation

• Performance anxiety disrupting neural signaling

Depression, anxiety, PTSD, and chronic stress all contribute.

How StemWave® Targets Erectile Dysfunction

StemWave® therapy addresses erectile dysfunction by targeting the underlying vascular causes, rather than temporarily enhancing erections.

Mechanism of Action:

• Stimulates angiogenesis (new blood vessel formation)

• Improves microcirculation within penile tissue

• Enhances endothelial nitric oxide activity

• Promotes tissue regeneration and smooth muscle health

Clinical Effect:

• Improved penile blood inflow

• Better ability to achieve and maintain erections

• Reduced dependence on erectile dysfunction medications over time

Clinical Study Results: Shockwave Therapy (STEMWAVE) for ED

1. Randomized Controlled Trials (RCTs)

• A 2021 RCT (N ≈ 76) found that low-intensity shockwave therapy significantly improved erectile function compared with a sham control at 3 months, measured by the International Index of Erectile Function (IIEF) score. The treated group had higher erection hardness scores at 6 months as well, with no reported adverse effects

  
  

• Another RCT in men with diabetic neuropathy and mild to moderate ED showed a significant increase in IIEF scores after shockwave therapy (mean IIEF improved from ~12.8 to ~17.5), whereas the sham group did not improve. Shockwave therapy also led to a greater proportion of men achieving erections sufficient for intercourse.

  
  

2. Meta-Analyses and Systematic Reviews

• Multiple systematic reviews and meta-analyses of RCTs report that low-intensity shockwave therapy consistently improved erectile function scores compared with placebo or sham therapy, suggesting a positive effect on both subjective function and objective hemodynamic measures (like penile blood flow).

• Reviews highlight that shockwave therapy may be particularly effective for men with vasculogenic ED and those who do not respond optimally to oral medications. However, quality and protocols vary across studies.

  
  

3. Long-Term and Real-World Data

• Earlier prospective studies indicated that about 60% of men experienced improved erectile performance after low-intensity shockwave therapy, with effects persisting several months after treatment.

• Follow-up research suggests that positive outcomes tend to be greater in men with mild–moderate ED, shorter duration of symptoms, and fewer underlying health conditions.

If you are interested in STEMWAVE for your ED, please contact Nipponclinic

www.nipponclinic.vegas